FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566150520> ?p ?o ?g. }

• W2566150520 abstract "Immune-mediated rejection of therapeutic proteins is a major hurdle for gene and protein replacement therapies for genetic disease. However, optimal induction and expansion of CD4+CD25+FoxP3+ regulatory T cells (Treg) counteract effector responses. We have previously shown that co-administration of antigen with rapamycin simultaneously promotes deletion of conventional CD4+ T cells and induction of Treg, so that we were able to induce tolerance to factors VIII and IX in treatment of the X-linked bleeding disorders hemophilia A and B. Here, we found in DO11.10 Rag−/− mice (homozygous for ovalbumin-peptide specific TCR, deficient in endogenous mature B, T or Treg cells) that the cytokine FMS-like receptor tyrosine kinase ligand (Flt3L) enhances the in vivo effect of rapamycin via selective expansion of plasmacytoid dendritic cells (pDC), resulting in substantially improved induction of OVA-specific Treg. This regimen, consisting of co-administration of rapamycin/Flt3L/OVA 3x/week for 1 month, also prevented OVA-specific CD8+ T cell responses in immune competent mice after intrasmuscular OVA gene transfer with an AAV1 vector. Flt3L signaling is critical to the generation and steady state expansion of both the conventional (CD11c+, CD8+CD11c+) and plasmacytoid (CD11cmid-loPDCA-1+) subsets of DC, which indirectly expands naturally occurring Treg. Interestingly, Flt3L-induced signaling in DC and DC precursors occurs through the mTOR pathway and can therefore be blocked by rapamycin, posing the question of why we are able to use these drugs synergistically for Treg induction. We find that limited doses of rapamycin selectively block Flt3L-induced expansion of conventional DC (cDC) but not pDC. Induced mTOR signaling is effectively blocked in cDC, while pDC have increased mTOR activity and are thus more resistant to inhibition by rapamycin. Consequently, Flt3L and rapamycin synergistically promote induction of antigen-specific Treg via selective expansion of pDC. During Flt3L/rapamycin/antigen co-administration, Treg induction is abrogated upon pDC depletion, thus confirming that Treg induction is pDC dependent. Similarly, Flt3L/antigen by itself fails to induce Treg, indicating that both pDC and rapamycin are required for Treg induction in this regimen.Finally, we are able to demonstrate in a therapeutic model for FVIII protein replacement therapy that combined Flt3L/rapamycin/FVIII treatment is superior in prevention of inhibitory antibody responses in hemophilia A mice (BALB/c F8e16−/−) when compared to rapamycin/FVIII only. In contrast, Flt3L/antigen administration in the absence of rapamycin, while enhancing activation induced cell death (AICD) of conventional CD4+ T cells, fails to induce Treg and also fails to induce tolerance to OVA or to FVIII. Thus, the differential effect of rapamycin on DC subsets can be exploited to improve tolerance induction via enhanced Treg induction, creating new opportunities for development of immune tolerance therapies with wide applicability." @default.
• W2566150520 created "2017-01-06" @default.
• W2566150520 creator A5008445793 @default.
• W2566150520 creator A5013948185 @default.
• W2566150520 creator A5018029184 @default.
• W2566150520 creator A5019108137 @default.
• W2566150520 creator A5034016497 @default.
• W2566150520 creator A5048239586 @default.
• W2566150520 creator A5079159088 @default.
• W2566150520 creator A5085683598 @default.
• W2566150520 creator A5086755266 @default.
• W2566150520 date "2015-05-01" @default.
• W2566150520 modified "2023-09-27" @default.
• W2566150520 title "293. Optimal In Vivo Treg Induction and Suppression of Immune Responses By Synergistic Use of Rapamycin and FLT3 Ligand" @default.
• W2566150520 doi "https://doi.org/10.1016/s1525-0016(16)33902-8" @default.
• W2566150520 hasPublicationYear "2015" @default.
• W2566150520 type Work @default.
• W2566150520 sameAs 2566150520 @default.
• W2566150520 citedByCount "0" @default.
• W2566150520 crossrefType "journal-article" @default.
• W2566150520 hasAuthorship W2566150520A5008445793 @default.
• W2566150520 hasAuthorship W2566150520A5013948185 @default.
• W2566150520 hasAuthorship W2566150520A5018029184 @default.
• W2566150520 hasAuthorship W2566150520A5019108137 @default.
• W2566150520 hasAuthorship W2566150520A5034016497 @default.
• W2566150520 hasAuthorship W2566150520A5048239586 @default.
• W2566150520 hasAuthorship W2566150520A5079159088 @default.
• W2566150520 hasAuthorship W2566150520A5085683598 @default.
• W2566150520 hasAuthorship W2566150520A5086755266 @default.
• W2566150520 hasBestOaLocation W25661505201 @default.
• W2566150520 hasConcept C104317684 @default.
• W2566150520 hasConcept C127716648 @default.
• W2566150520 hasConcept C154317977 @default.
• W2566150520 hasConcept C167672396 @default.
• W2566150520 hasConcept C202751555 @default.
• W2566150520 hasConcept C203014093 @default.
• W2566150520 hasConcept C2776090121 @default.
• W2566150520 hasConcept C2777702733 @default.
• W2566150520 hasConcept C2779727006 @default.
• W2566150520 hasConcept C2779919695 @default.
• W2566150520 hasConcept C55493867 @default.
• W2566150520 hasConcept C79484868 @default.
• W2566150520 hasConcept C86803240 @default.
• W2566150520 hasConcept C8891405 @default.
• W2566150520 hasConcept C95444343 @default.
• W2566150520 hasConceptScore W2566150520C104317684 @default.
• W2566150520 hasConceptScore W2566150520C127716648 @default.
• W2566150520 hasConceptScore W2566150520C154317977 @default.
• W2566150520 hasConceptScore W2566150520C167672396 @default.
• W2566150520 hasConceptScore W2566150520C202751555 @default.
• W2566150520 hasConceptScore W2566150520C203014093 @default.
• W2566150520 hasConceptScore W2566150520C2776090121 @default.
• W2566150520 hasConceptScore W2566150520C2777702733 @default.
• W2566150520 hasConceptScore W2566150520C2779727006 @default.
• W2566150520 hasConceptScore W2566150520C2779919695 @default.
• W2566150520 hasConceptScore W2566150520C55493867 @default.
• W2566150520 hasConceptScore W2566150520C79484868 @default.
• W2566150520 hasConceptScore W2566150520C86803240 @default.
• W2566150520 hasConceptScore W2566150520C8891405 @default.
• W2566150520 hasConceptScore W2566150520C95444343 @default.
• W2566150520 hasLocation W25661505201 @default.
• W2566150520 hasOpenAccess W2566150520 @default.
• W2566150520 hasPrimaryLocation W25661505201 @default.
• W2566150520 hasRelatedWork W1495974241 @default.
• W2566150520 hasRelatedWork W150881044 @default.
• W2566150520 hasRelatedWork W1607928414 @default.
• W2566150520 hasRelatedWork W1852769543 @default.
• W2566150520 hasRelatedWork W1918052238 @default.
• W2566150520 hasRelatedWork W1969613993 @default.
• W2566150520 hasRelatedWork W1993208556 @default.
• W2566150520 hasRelatedWork W2023925257 @default.
• W2566150520 hasRelatedWork W2041586031 @default.
• W2566150520 hasRelatedWork W2076369967 @default.
• W2566150520 hasRelatedWork W2085978214 @default.
• W2566150520 hasRelatedWork W2170748847 @default.
• W2566150520 hasRelatedWork W2259611172 @default.
• W2566150520 hasRelatedWork W2481745253 @default.
• W2566150520 hasRelatedWork W2536794138 @default.
• W2566150520 hasRelatedWork W2590096315 @default.
• W2566150520 hasRelatedWork W2767763842 @default.
• W2566150520 hasRelatedWork W2791195153 @default.
• W2566150520 hasRelatedWork W2980249035 @default.
• W2566150520 hasRelatedWork W3105568305 @default.
• W2566150520 isParatext "false" @default.
• W2566150520 isRetracted "false" @default.
• W2566150520 magId "2566150520" @default.
• W2566150520 workType "article" @default.